Danantara Invests $2.5 Billion in JBS to Strengthen Indonesia's Protein Sector

Danantara Indonesia, through its investment arm Danantara Investment Management (DIM), has entered into a strategic partnership with JBS Group, a leading global protein producer. This collaboration is marked by an initial investment of $2.5 billion, approximately IDR 44.6 trillion (based on an exchange rate of IDR 17,858), for a 25% stake in a joint venture that will manage JBS's operations in Australia and New Zealand.

The total capital available for this venture is projected to reach $5 billion, which will be utilized for acquisitions and greenfield investments in Indonesia, Southeast Asia, Australia, and New Zealand. This partnership aims to leverage JBS's established business networks and management expertise to enhance the protein sector in Indonesia.

“This strategic partnership reflects Danantara Indonesia's commitment to building collaboration with global partners aligned with our investment mandate.”Pandu Patria Sjahrir, CIO of Danantara Indonesia

Pandu Patria Sjahrir, Chief Investment Officer of Danantara, emphasized that this strategic partnership reflects Danantara's commitment to collaborating with global partners in sectors that offer sustainable global relevance and value creation. He stated that the partnership demonstrates Danantara Indonesia's commitment to building collaboration with global partners aligned with their investment mandate.

Gilberto Tomazoni, Global CEO of JBS, highlighted that this partnership is a crucial step in the company's long-term growth strategy in Southeast Asia. He noted that together with Danantara, they are in a strong position to expand their presence in Indonesia and Southeast Asia, strengthen the regional protein supply chain, and accelerate the development of the protein sector in Indonesia.

“Together with Danantara, we are in a strong position to expand our presence in Indonesia and Southeast Asia, strengthen the regional protein supply chain, and accelerate the development of the protein sector in Indonesia.”Gilberto Tomazoni, Global CEO of JBS

The joint venture is expected to provide Danantara with access to a well-established business ecosystem and the opportunity to benefit from the experience and distribution channels of one of the world's largest protein companies. JBS has a solid track record in creating value through consistent growth, market expansion, and adaptability amidst industry fluctuations.

As the transaction is still pending regulatory approval, Danantara has expressed its commitment to fulfilling all necessary requirements in accordance with prevailing regulations.